Most Alzheimer's patients would pay up to $26500 a year for a new Leqembi treatment

Retrieved on: 2023-01-10 00:32:58

Tags for this article:

Click the tags to see associated articles and topics

Most Alzheimer's patients would pay up to $26500 a year for a new Leqembi treatment. View article details on hiswai:

Excerpt

The Food and Drug Administration granted accelerated approval Friday to Biogen and Eisai's monoclonal antibody after the treatment appeared to ...

Article found on: www.thebharatexpressnews.com